These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 11510627)

  • 1. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of new histamine H1 receptor antagonists.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1999 May; 36(5):329-52. PubMed ID: 10384858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers.
    Chaufour S; Le Coz F; Denolle T; Dubruc C; Cimarosti I; Deschamps C; Ulliac N; Delhotal-Landes B; Rosenzweig P
    Int J Clin Pharmacol Ther; 1998 May; 36(5):286-91. PubMed ID: 9629994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.
    Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P
    J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.
    Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL
    Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.
    Schran HF; Petryk L; Chang CT; O'Connor R; Gelbert MB
    J Clin Pharmacol; 1996 Oct; 36(10):911-22. PubMed ID: 8930778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.
    Simons FE; Simons KJ
    Clin Pharmacokinet; 1991 Nov; 21(5):372-93. PubMed ID: 1685361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of reboxetine, a selective norepinephrine reuptake inhibitor for the treatment of patients with depression.
    Fleishaker JC
    Clin Pharmacokinet; 2000 Dec; 39(6):413-27. PubMed ID: 11192474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
    Purohit A; Mélac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.
    Stangier J; Stähle H; Rathgen K; Fuhr R
    Clin Pharmacokinet; 2008; 47(1):47-59. PubMed ID: 18076218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling.
    Mesnil F; Dubruc C; Mentre F; Huet S; Mallet A; Thenot JP
    J Pharmacokinet Biopharm; 1997 Apr; 25(2):125-47. PubMed ID: 9408856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.